172 related articles for article (PubMed ID: 17482853)
1. Changes in macrophage morphology in a Gaucher disease model are dependent on CTP:phosphocholine cytidylyltransferase alpha.
Kacher Y; Golan A; Pewzner-Jung Y; Futerman AH
Blood Cells Mol Dis; 2007; 39(1):124-9. PubMed ID: 17482853
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide.
Bodennec J; Pelled D; Riebeling C; Trajkovic S; Futerman AH
FASEB J; 2002 Nov; 16(13):1814-6. PubMed ID: 12223447
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes.
Trajkovic-Bodennec S; Bodennec J; Futerman AH
Blood Cells Mol Dis; 2004; 33(1):77-82. PubMed ID: 15223015
[TBL] [Abstract][Full Text] [Related]
4. Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition.
Yatziv S; Newburg DS; Livni N; Barfi G; Kolodny EH
J Lab Clin Med; 1988 Apr; 111(4):416-20. PubMed ID: 3351378
[TBL] [Abstract][Full Text] [Related]
5. Impaired IL-10 transcription and release in animal models of Gaucher disease macrophages.
Kacher Y; Futerman AH
Blood Cells Mol Dis; 2009; 43(1):134-7. PubMed ID: 19380242
[TBL] [Abstract][Full Text] [Related]
6. Recombinant glucocerebrosidase uptake by Gaucher disease human osteoblast culture model.
Lamghari M; Barrias CC; Sá Miranda C; Barbosa MA
Blood Cells Mol Dis; 2005; 35(3):348-54. PubMed ID: 16125984
[TBL] [Abstract][Full Text] [Related]
7. Oxysterol activation of phosphatidylcholine synthesis involves CTP:phosphocholine cytidylyltransferase alpha translocation to the nuclear envelope.
Gehrig K; Lagace TA; Ridgway ND
Biochem J; 2009 Feb; 418(1):209-17. PubMed ID: 18980580
[TBL] [Abstract][Full Text] [Related]
8. Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease.
Berger J; Lecourt S; Vanneaux V; Rapatel C; Boisgard S; Caillaud C; Boiret-Dupré N; Chomienne C; Marolleau JP; Larghero J; Berger MG
Br J Haematol; 2010 Jul; 150(1):93-101. PubMed ID: 20507316
[TBL] [Abstract][Full Text] [Related]
9. AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.
McEachern KA; Nietupski JB; Chuang WL; Armentano D; Johnson J; Hutto E; Grabowski GA; Cheng SH; Marshall J
J Gene Med; 2006 Jun; 8(6):719-29. PubMed ID: 16528760
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.
Manning-Boğ AB; Schüle B; Langston JW
Neurotoxicology; 2009 Nov; 30(6):1127-32. PubMed ID: 19576930
[TBL] [Abstract][Full Text] [Related]
11. CTP:phosphocholine cytidylyltransferase α (CCTα) and lamins alter nuclear membrane structure without affecting phosphatidylcholine synthesis.
Gehrig K; Ridgway ND
Biochim Biophys Acta; 2011 Jun; 1811(6):377-85. PubMed ID: 21504799
[TBL] [Abstract][Full Text] [Related]
12. Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells.
Newburg DS; Shea TB; Yatziv S; Raghavan SS; McCluer RH
Exp Mol Pathol; 1988 Jun; 48(3):317-23. PubMed ID: 3371456
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulation of pulmonary phosphatidylcholine synthesis.
Tseu I; Ridsdale R; Liu J; Wang J; Post M
Am J Respir Cell Mol Biol; 2002 Apr; 26(4):506-15. PubMed ID: 11919088
[TBL] [Abstract][Full Text] [Related]
14. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
Mizukami H; Mi Y; Wada R; Kono M; Yamashita T; Liu Y; Werth N; Sandhoff R; Sandhoff K; Proia RL
J Clin Invest; 2002 May; 109(9):1215-21. PubMed ID: 11994410
[TBL] [Abstract][Full Text] [Related]
15. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by lipophilic activators of CTP:phosphocholine cytidylyltransferase alpha (CCTalpha).
Lagace TA; Ridgway ND
Biochem J; 2005 Dec; 392(Pt 3):449-56. PubMed ID: 16097951
[TBL] [Abstract][Full Text] [Related]
17. Chemical inhibition of β-glucocerebrosidase does not affect phagocytosis and early containment of Leishmania by murine macrophages.
Ribeiro H; Rocha MI; Castro H; Macedo MF
Exp Parasitol; 2020 Sep; 216():107939. PubMed ID: 32535115
[TBL] [Abstract][Full Text] [Related]
18. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.
van Weely S; van den Berg M; Barranger JA; Sa Miranda MC; Tager JM; Aerts JM
J Clin Invest; 1993 Mar; 91(3):1167-75. PubMed ID: 8450045
[TBL] [Abstract][Full Text] [Related]
19. Participation of prostaglandin D2 in the mobilization of the nuclear-localized CTP:phosphocholine cytidylyltransferase alpha in renal epithelial cells.
Favale NO; Pescio LG; Santacreu BJ; Márquez MG; Sterin-Speziale NB
Biochim Biophys Acta; 2016 Jun; 1861(6):513-23. PubMed ID: 27032756
[TBL] [Abstract][Full Text] [Related]
20. CTP:phosphocholine cytidylyltransferase: Function, regulation, and structure of an amphitropic enzyme required for membrane biogenesis.
Cornell RB; Ridgway ND
Prog Lipid Res; 2015 Jul; 59():147-71. PubMed ID: 26165797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
